Rush Votes “Yes” in Support of the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3)
WASHINGTON — Today, U.S. Representative Bobby L. Rush (D-Ill.) voted in support of H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act. This bill, among other important provisions, lowers the cost of prescription drugs by empowering the Secretary of Health and Human Services (HHS) to negotiate directly with drug manufacturers for the prices of certain drugs that lack competition. The bill passed the House of Representatives by a bipartisan vote of 230 – 192.
“I am immensely proud to have voted for this historic piece of legislation, which will allow hundreds of thousands of people in my district to access lifesaving drugs that they could not otherwise afford. This transformative bill will also provide millions of seniors across the country with comprehensive vision, dental, and hearing coverage, which is currently not covered under Medicare.
“Throughout this process, I have fought to give seniors even more access to affordable health care by pushing to lower the cap on out-of-pocket expenses to $1,500 and to increase vision benefits for seniors. Although these provisions were not ultimately included in the final bill, I was proud to vote for H.R. 3, and I will continue to fight for seniors in my district and across the country to ensure that prescription drugs and medical care are both accessible and affordable,” said Rep. Rush.
H.R. 3 also establishes a mandatory rebate for drug manufacturers of certain covered Part B and Part D drugs that increase in price faster than inflation. In addition, the bill changes the structure of the standard benefit design for Medicare Part D and creates a $,2000 out-of-pocket maximum for Part D enrollees.
H.R.3 also heavily invests in scientific research by the National Institutes of Health (NIH) and the Food and Drug Administration, and increases funding for Community Health Centers, which provide high-quality and lifesaving medical care to one in nine Illinois residents.